1.44
1.03%
-0.015
アフターアワーズ:
1.44
前日終値:
$1.455
開ける:
$1.45
24時間の取引高:
2,602
Relative Volume:
0.06
時価総額:
$7.85M
収益:
-
当期純損益:
$-2.25M
株価収益率:
-3.0252
EPS:
-0.476
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-20.00%
1か月 パフォーマンス:
-18.64%
6か月 パフォーマンス:
-37.12%
1年 パフォーマンス:
+46.97%
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
XTLB を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.44 | 7.85M | 0 | -2.25M | 0 | -0.40 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2015-05-08 | 開始されました | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr (XTLB) 最新ニュース
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks
XTL Biopharmaceuticals Announces Upcoming Shareholder MeetingTipRanks.com - TipRanks
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.TipRanks.com - TipRanks
Enhance Your Investment Strategy with Altman Z-Score Screener By Investing.com - Investing.com India
XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher - Markets Insider
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance
X T L Biopharmaceuticals Ltd Adr (XTLB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):